IMUX
Immunic Inc
NASDAQ: IMUX · HEALTHCARE · BIOTECHNOLOGY
$12.00
-11.50% today
Updated 2026-06-05
Market cap
$173.95M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.77
Dividend yield
—
52W range
$5 – $16
Volume
1.4M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-50.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$44.67
+272.25%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -49.97 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-17.30M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-120.41M | $-93.61M | $-100.51M | $-97.17M | $-32.59M |
| EPS | — | — | — | — | $-4.77 |
| Free cash flow | $-65.26M | $-71.16M | $-85.03M | $-85.97M | $-17.30M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Immunic Inc trades at $12.00. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -49.97, it sits in the distress.
Frequently asked questions
What is Immunic Inc's stock price?
Immunic Inc (IMUX) trades at $12.00.
Is Immunic Inc overvalued?
Immunic Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Immunic Inc (IMUX)?
The 12-month analyst consensus target is $44.67, about 272.3% above the current $12.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Immunic Inc's Altman Z-Score is -49.97, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-68.96%
Beta1.21
50D MA$11.67
200D MA$8.98
Shares out0.01B
Float0.01B
Short ratio—
Avg volume1.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—